MYCOF - Mydecine Innovations files patent related to nanoemulsion technology

Mydecine Innovations (OTCPK:MYCOF) announces the filing of a technology patent that allows for the creation of formulations that utilize nanoemulsion technology to enhance, stabilize and make repeatable properties of ingredients from traditional medicine. The patent will cover formulations that are generally recognized as safe by FDA (GRAS-certified) and leverages increased bioavailability to enhance the properties available to consumers. Nanoemulsion is an advanced mode of drug delivery that has been developed to overcome the major drawbacks associated with conventional drug delivery systems.

For further details see:

Mydecine Innovations files patent related to nanoemulsion technology